<DOC>
	<DOCNO>NCT00530257</DOCNO>
	<brief_summary>This study investigate whether OROS-methylphenidate improves performance different aspect attention memory child Attention-Deficit Hyperactivity Disorder ( ADHD ) .</brief_summary>
	<brief_title>Study Effects Osmotic-Release Oral System ( OROS ) Methylphenidate ( Concerta ) Attention Memory</brief_title>
	<detailed_description>This study investigate effect Osmotic-Release Oral System ( OROS ) -methylphenidate , long-acting stimulant , multiple dimension attention work memory . Specifically , investigate follow two hypothesis : ( 1 ) OROS-methylphenidate result improve performance measure assess multiple domain attention , include sustained attention , attentional control , selective attention , divide attention , ( 2 ) OROS-methylphenidate result improve performance measure work memory . In addition use study collect pilot data whether magnitude effect OROS-methylphenidate varies across different component attention work memory whether improvement across measure helpful predict parent teacher rating improvement .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Meets Diagnostic Statistical ManualIV Edition ( DSMIV ) Criteria ADHD.Combined Type Parent Teacher Ratings &gt; 85 percentile inattention and/or hyperactivity/impulsivity scale Estimated Intelligence Quotient ( IQ ) &gt; 80 Wechsler Abbreviated Scale Intelligence similar IQ test Past current diagnosis Tourette syndrome chronic tic disorder , Pervasive Developmental Disorder ( PDD ) , Cerebral Palsy , Head Injury require hospitalization , psychotic disorder , hypertension , glaucoma , cardiovascular disease , severe narrow gastrointestinal tract , epilepsy Current diagnosis bipolar disorder , obsessivecompulsive disorder serious enough warrant separate treatment , suicidal homicidal behavior ideation Use within 14days monoamine oxidase inhibitor History side effect methylphenidate preparation require stopping medication Inability swallow capsule tablet Chronic treatment coumarin , clonidine , tricyclic antidepressant</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>Methylphenidate</keyword>
	<keyword>Attention</keyword>
	<keyword>Working Memory</keyword>
</DOC>